Skip to content

Innovative Care Pathway in Physical Activity and Behavior Change in Coronary Patients Post-cardiac Rehabilitation

Innovative Care Pathway in Physical Activity and Behavior Change in Coronary Patients Post Cardiac Rehabilitation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06345807
Acronym
APIC
Enrollment
192
Registered
2024-04-03
Start date
2024-10-31
Completion date
2026-11-30
Last updated
2024-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Patient, Individualised Physical Activity Program

Keywords

cardiac rehabilitation, ischemic heart disease, physical activity, wearables

Brief summary

The objective of this 18-month research is to show the effectiveness of an individualized physical activity( PA) compared to standard PA management and voluntary PA, to achieve a change in the behavior of the coronary patient.

Interventions

OTHERIndividuals activity programs

activity program will be adjusted every week by practitioner for each patient following data coming from the wearable device ( connected whatch and bellt for 12 months)

pre established program without adjustement. The patient has connected whatch and bellt for 12 months

OTHERno Physical Activity program

no Physical Activity (PA)program but just PA recommendations.PA is carried out independently (common practice).The patient has connected whatch and bellt for 12 months

Sponsors

Elsan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

interventional study, randomized in 3 parallel groups, single center,

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Post-infarction coronary artery patient aged 18 years and older, with no gender difference. * Patients engaged in a follow-up care and cardiovascular rehabilitation program at the Supervaltech center. * Patient at low to moderate RARE risk of complication (RARE score 2 to 3) * Patients equipped with smartphones, laptops or other equipment compatible with downloading an application with their personal ID * Patient able to understand French for the purpose of conducting the study. * Affiliated member or beneficiary of a social security scheme. * Participant who has been informed and has given free, informed and written consent (no later than the day of inclusion and before any examination required by the research).

Exclusion criteria

* Patients with a formal contraindication to physical activity such as: unstabilized coronary syndrome, decompensated heart failure, severe ventricular arrhythmias, intracardiac thrombus at risk embolic, PAH, moderate pericardial effusion, history of thrombophlebitis with or without pulmonary embolism, severe and/or symptomatic left ventricular ejection obstruction. * Patients with ongoing infectious disease * Participant whose physical and/or psychological health is severely impaired, which in the opinion of the investigator may affect the study participant's compliance. * Participant included in other research * Participant in a period of exclusion from another research still in progress at the time of inclusion. * Protected participant: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision. * Pregnant, breastfeeding or parturient women. * Participant hospitalized without consent.

Design outcomes

Primary

MeasureTime frameDescription
6 minutes walk test18 monthspatient behaviour change measured with the six minute walk test distance

Contacts

Primary Contactchristine Blanc
christine.blanc@elsan.care0468562895
Backup ContactDeva BAS, MD
0468874022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026